Paper · 40655152
References163
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 163
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17672864 | Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression. | Cell Microbiol | 2008 | https://conductscience.org/library/papers/17672864 | PubMed |
| 2 | 38975233 | Interferon-α could induce liver steatosis to promote HBsAg loss by increasing triglyceride level. | Heliyon | 2024 | https://conductscience.org/library/papers/38975233 | PubMed |
| 3 | 9300041 | Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G-->A hypermutation. | Virology | 1997 | https://conductscience.org/library/papers/9300041 | PubMed |
| 4 | 39854241 | Antiviral Mx proteins have an ancient origin and widespread distribution among eukaryotes. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/39854241 | PubMed |
| 5 | 31333675 | The Commensal Microbiota and Viral Infection: A Comprehensive Review. | Front Immunol | 2019 | https://conductscience.org/library/papers/31333675 | PubMed |
| 6 | 37475028 | Triple motif proteins 19 and 38 correlated with treatment responses and HBsAg clearance in HBeAg-negative chronic hepatitis B patients during peg-IFN-α therapy. | Virol J | 2023 | https://conductscience.org/library/papers/37475028 | PubMed |
| 7 | 34021034 | RNA helicase DDX5 enables STAT1 mRNA translation and interferon signalling in hepatitis B virus replicating hepatocytes. | Gut | 2022 | https://conductscience.org/library/papers/34021034 | PubMed |
| 8 | 30755454 | Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease. | J Exp Med | 2019 | https://conductscience.org/library/papers/30755454 | PubMed |
| 9 | 38905278 | Guanylate-Binding Protein 1 (GBP1) Enhances IFN-α Mediated Antiviral Activity against Hepatitis B Virus Infection. | Pol J Microbiol | 2024 | https://conductscience.org/library/papers/38905278 | PubMed |
| 10 | 35080443 | Myxovirus Resistance Protein A as a Marker of Viral Cause of Illness in Children Hospitalized with an Acute Infection. | Microbiol Spectr | 2022 | https://conductscience.org/library/papers/35080443 | PubMed |
| 11 | 33811250 | Bayesian analysis of cytokines and chemokine identifies immune pathways of HBsAg loss during chronic hepatitis B treatment. | Sci Rep | 2021 | https://conductscience.org/library/papers/33811250 | PubMed |
| 12 | 38376650 | Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B. | Hepatol Int | 2024 | https://conductscience.org/library/papers/38376650 | PubMed |
| 13 | 19161414 | Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. | Immunol Rev | 2008 | https://conductscience.org/library/papers/19161414 | PubMed |
| 14 | 37166302 | Mitochondrial Glycerol-3-Phosphate Dehydrogenase Restricts HBV Replication via the TRIM28-Mediated Degradation of HBx. | J Virol | 2023 | https://conductscience.org/library/papers/37166302 | PubMed |
| 15 | 33424840 | Immunomodulation Induced During Interferon-α Therapy Impairs the Anti-HBV Immune Response Through CD24+CD38hi B Cells. | Front Immunol | 2020 | https://conductscience.org/library/papers/33424840 | PubMed |
| 16 | 16699026 | Lipid-mediated introduction of hepatitis B virus capsids into nonsusceptible cells allows highly efficient replication and facilitates the study of early infection events. | J Virol | 2006 | https://conductscience.org/library/papers/16699026 | PubMed |
| 17 | 25048716 | Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections. | Hepatology | 2015 | https://conductscience.org/library/papers/25048716 | PubMed |
| 18 | 35135717 | Microbiota regulation of viral infections through interferon signaling. | Trends Microbiol | 2022 | https://conductscience.org/library/papers/35135717 | PubMed |
| 19 | 33868257 | The Functional and Antiviral Activity of Interferon Alpha-Inducible IFI6 Against Hepatitis B Virus Replication and Gene Expression. | Front Immunol | 2021 | https://conductscience.org/library/papers/33868257 | PubMed |
| 20 | 33845868 | Potential capacity of interferon-α to eliminate covalently closed circular DNA (cccDNA) in hepatocytes infected with hepatitis B virus. | Gut Pathog | 2021 | https://conductscience.org/library/papers/33845868 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/40655152/references